Meritxell Huch Ortega | |
---|---|
Born | 1978 |
Alma mater | University of Barcelona |
Scientific career | |
Institutions | Max Planck Institute of Molecular Cell Biology and Genetics University of Cambridge Centre for Genomic Regulation Hubrecht Institute |
Thesis | Estudi de l'eficàcia antitumoral d'adenovirus redirigits a receptors FGFR i valoració de la selectivitat dels virus AdCK7pLuc i AduPARpLuc en models de càncer de pancrees (2007) |
Meritxell Huch (Barcelona, 1978) [1] is a stem cell biologist and director at the Max Planck Institute of Molecular Cell Biology and Genetics. Her research considers tissue regeneration and the development of tissue-specific disease models for human organs. She was awarded a European Research Council Consolidator Grant in 2023.
After college Huch decided she wanted to work in science because of a desire to understand how aspirin works. [2] Huch was an undergraduate student at the University of Barcelona, where she studied pharmaceutical sciences. [3] She remained there for her graduate studies, earning a Master in 2003 and doctorate in 2007. She completed her PhD research in the Centre for Genomic Regulation, where she worked alongside Cristina Fillat. [4] After completing her doctoral research she spent a year as a postdoctoral fellow before moring to the Hubrecht Institute on a Marie Curie Fellowship. In Utrecht she worked in the laboratory of Hans Clevers, where she isolated the stem cells responsible for the turnover of the adult stomach. [5]
Huch was appointed a Sir Henry Dale Research Fellow at the Gurdon Institute at the University of Cambridge. [3] [6] She held a joint position with The Wellcome Trust and the Department of Physiology. After five years in Cambridge, Huch joined the Max Planck Institute of Molecular Cell Biology and Genetics as one of the first members of the Lise Meitner Excellence Program. [6] [7] She was appointed to the board of directors in 2022. [8]
Inflammation and tissue damage are associated with chronic liver disease and cancer. [2] Her group have extensively developed human organoid models to study the molecular basis of adult tissue regeneration. [9] [10] Having identified stem cells responsible for the rapid turnover of the adult stomach, Huch showed that they could be maintained in culture. [5] Next she moved on to liver cells, demonstrating the replicative potential of progenitor cells during regeneration and showing they are promising candidates for future therapeutic interventions in liver diseases. [5] [11] Her research has the potential to reduce the use of animals in scientific research. [12] [13]
Adult stem cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells, they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells.
An organoid is a miniaturized and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural and biological complexity of that organ. They are derived from one or a few cells from a tissue, embryonic stem cells or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and The Scientist names it as one of the biggest scientific advancements of 2013. Scientists and engineers use organoids to study development and diseases in the laboratory and industry for drug discovery and development, personalized diagnostics and medicine, gene and cell therapies, tissue engineering and regenerative medicine.
The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) is a biology research institute located in Dresden, Germany. It was founded in 1998 and was fully operational in 2001. Research groups in the institute work in molecular biology, cell biology, developmental biology, biophysics, and systems biology supported by various facilities.
The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.
Anthony Arie Hyman is a British scientist and director at the Max Planck Institute of Molecular Cell Biology and Genetics.
Johannes (Hans) Carolus Clevers is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022. Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research and at the Princess Máxima Center; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at the University of Utrecht.
Jamie A. Davies FRSE FLSW is a British scientist, Professor of Experimental Anatomy at the University of Edinburgh, and leader of a laboratory in its Centre for Integrative Physiology. He works in the fields of Developmental biology, Synthetic biology, and Tissue engineering. He is also Principal Investigator for the IUPHAR/BPS Guide to Pharmacology database.
Elly Margaret Tanaka is a biochemist and senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. Tanaka studies the molecular cell biology of limb and spinal cord regeneration as well as the evolution of regeneration.
Melissa Helen Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.
Heather A. Harrington is an applied mathematician interested in applied algebra and geometry, dynamical systems, chemical reaction network theory, topological data analysis, and systems biology. Since 2020, she is professor of mathematics and Royal Society University Research Fellow at the Mathematical Institute, University of Oxford, where she heads the Algebraic Systems Biology group. In 2023, she became a director at the Max Planck Institute of Molecular Cell Biology and Genetics, where she is also leading the interinstitutional Center for Systems Biology Dresden (CSBD) together with partners from the Technical University Dresden and the Max Planck Institute for the Physics of Complex Systems.
Madeline Lancaster is an American developmental biologist studying neurological development and diseases of the brain. Lancaster is a group leader at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, UK.
Suzanne Eaton was an American scientist and professor of molecular biology at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany.
Jürgen Knoblich is a German molecular biologist. Since 2018, he is the interim Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Valentina Greco is an Italian-born biologist who teaches at the Yale School of Medicine as the Carolyn Walch Slayman Professor of Genetics and is an Associate Professor in the Cell Biology and Dermatology departments. Her research focuses on the role of skin stem cells in tissue regeneration.
Paola Arlotta is the Golub Family Professor of Stem Cell and Regenerative Biology at Harvard University and chair of the Harvard Stem Cell and Regenerative Biology (HSCRB). Her research focuses on the development of neuron types in the cerebral cortex. She is best known for her work using 3D cerebral organoids derived from human induced pluripotent stem cells (iPSCs) to study cortical development in neurodegenerative and neuropsychiatric disorders.
Matthias Lutolf is a bio-engineer and a professor at EPFL where he leads the Laboratory of Stem Cell Bioengineering. He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models. In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.
Caren Norden is a German biophysicist who is Deputy Director for Science at the Instituto Gulbenkian de Ciência. She works as a group leader at the Max Planck Institute of Molecular Cell Biology and Genetics. Her research considers the cell biology of tissue morphogenesis.
Prisca Liberali is an Italian chemist who is a senior group leader at the Friedrich Miescher Institute for Biomedical Research. Her research takes a systems biology approach to understand the behaviour of multi-cellular systems. She was awarded the EMBO Gold Medal and EMBO Membership in 2022.
Anjali Kusumbe is a British-Indian biologist who is the Head of the Tissue and Tumour Microenvironments Group at the Medical Research Council Weatherall Institute of Molecular Medicine at the University of Oxford. She was awarded the Royal Microscopical Society Award for Life Sciences in 2022.
Stephan Wolfgang Grill is a German biophysicist.